{"name":"Windward Bio","slug":"windward-bio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNZ3AyRVY1TTZHVUZmY1VFNzQ5UzFCallTeDB2RzV4bDB4YXE1XzBtWnRMMTlkQ2ZQZ0xKV2xXZEQwT0IxNm44Z0VPTzBzQ3VKNURIbzFCQXJwQ1ZmWUw5cGwxUGNWSkZOT29OMEV4a3RIM3RHUDhUTjYtNkQ1R3p1V09pcEJJT2JwT3Q1Vng0WkYxUjVVdTZBdzVvMFk2alJURGh4VUswS1kyVVlBb1VjWmxDSGhWR0NKazFQb3JCREdmTDJPbDNBekg4UEhLcXl6UDdBLVZmcEtDTkU4dC1WYXBQckpSZXRs?oc=5","date":"2026-03-30","type":"deal","source":"BioSpace","summary":"Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth - BioSpace","headline":"Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1MUEl6MjZxXzhZa3FKWFBORWx0aWk0VUtWbkFObEVJb25haGlMQU1QMHZfVGVIeVNKdFFwLTN3RlZGUGgyRV8tVUlnUDFSc21aNkNj?oc=5","date":"2025-12-22","type":"pipeline","source":"FirstWord Pharma","summary":"Windward bags its second China-sourced TSLP-targeting programme - FirstWord Pharma","headline":"Windward bags its second China-sourced TSLP-targeting programme","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQN3oyYlZzTlVzVHlKbFpuekd3Q1VVNU9kZGRYYzFFclFsSjFfOG1MaXlQOUFTd2hrVmVzblcwMjRnSERvYzZGRTZIbUJPR3FZcjVSNEVoemJVOWRtd2NpNDY2aTBBV1gxYS1iLUwxaF90WXptRGJkUkxKTjdTRkNpLXRUWUNIR2ZFSHZSNHdVR0FRVjZyWm9ZLUVOaC1yV3NmbnBFOHlTRlhsODNR?oc=5","date":"2025-12-22","type":"deal","source":"The Pharma Letter","summary":"Windward Bio licenses immunology bispecific from Qyuns for $700M - The Pharma Letter","headline":"Windward Bio licenses immunology bispecific from Qyuns for $700M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE9UcTZfaFI5OV9PZkh3NXNqbVpvT1ZWeVRTTlhTWUdQVVRjTmYzNkR0RE1INDlWdXh3RC11b3hsWUdIZk5sajVOd1ZFVjctT1JGb3A0NDNOMA?oc=5","date":"2025-12-22","type":"pipeline","source":"The Pharma Letter","summary":"Windward Bio - The Pharma Letter","headline":"Windward Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQazlVQU1Xc0NYN1hjVHBmQ1JfckRPdWIzZ3BYajhzSUdGbzk3NG1UTjZJYUVnYzVXYUlrQWxmMWtYN1Ytc0IyMnBzYUxpX1lZXzNBd05SNUkzblo5akdiMF9CSnhjaUwwUXBZQ3J4R2ItamJhU285RTN4RHN2WkpHbDFia3U5V0RVUFR1TmMyU0R4WXpSQ2lpcHpYUURhWm5pdmVqdVZsWHJhaWlwWkliU2ZxOUU2Y253X190d3YwT21NQ04wcVE?oc=5","date":"2025-12-22","type":"deal","source":"Fierce Biotech","summary":"Novo Holdings-backed Windward buys rights to Qyuns' clinical-stage immunology bispecific in $700M deal - Fierce Biotech","headline":"Novo Holdings-backed Windward buys rights to Qyuns' clinical-stage immunology bispecific in $700M deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1MWjBZcWRpaEhSZGJuOWR1c2wyZ2xOOHdsdTBPbnhmdS1qeVdGUnV2bGE4QkNQdHI1TnREM20xRlc4WmNfdTIzUVJscVhzekNmakxZN0xYQUVUNlhxN3FvRkk1V21aNkZwN2ZNQ3pUU3ZmNGQycTFCanc4MA?oc=5","date":"2025-07-24","type":"trial","source":"Clinical Trials Arena","summary":"Windward Bio launches Phase II trial of asthma treatment - Clinical Trials Arena","headline":"Windward Bio launches Phase II trial of asthma treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxPZTRqVTRIR3NFU0pBbXJ4MmJmclpCaUFYU01OWlgxNS05a0hlSWhrbnhLMzJzZF9iYm5Zbi1CT3F6dFZ5TUVBeG5uZnJRMU5Hd3Nxek1RdUVFV0NqZ0g5UV9zZDh1dHN3d29FSHlLcnpnZ0hUY29TN1RCcmNuYkppMWQ5bEJRUzMwakdyOXEwcDFjcnlhblA1UmpSakdVbkFGTFBWZVVOS2VQRlB2NUdmOU9GWkxsN1BsQUNpNGpvaGZxaVhPT2hLXzVGYk1tejd6VDhwdy1WcFAxSDRMRkxmUkRuXzVQWjFJd3NTcjBvWXJRYWc?oc=5","date":"2025-07-23","type":"trial","source":"PR Newswire","summary":"Kelun-Biotech's Partner Windward Bio Announces Initiation of a Global Phase 2 Asthma Trial of SKB378/WIN378 - PR Newswire","headline":"Kelun-Biotech's Partner Windward Bio Announces Initiation of a Global Phase 2 Asthma Trial of SKB378/WIN378","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOYWZvbDRJbXhYa1BjcUp5dU5PNklRdUpuV3AydTZiQndHa0ZHTm1tNk9rOWMtdmJUTlpreVljNXRiOE96UFYxQ3g0WXNHbWs5X19VOUlpODBHbHhqUURyRS0wWlJqcDRielFCNldPdVBwc1N5UWs0LU5YYnNZTVZjWm5DcjU4dGowX1lnRXMxRHptUEVPckR5V3VfWElsY0ZtTmlTV2o1b3JMOXpJbnp3UVYzMVdERnRQa1pxWUZhanRCdnVUb3hyWDRtN09oSFc4bWc?oc=5","date":"2025-02-06","type":"regulatory","source":"BioPharma APAC","summary":"Harbour BioMed Secures NMPA Approval for HBM9378/SKB378 and Signs $970M Global Licensing Deal - BioPharma APAC","headline":"Harbour BioMed Secures NMPA Approval for HBM9378/SKB378 and Signs $970M Global Licensing Deal","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPZk9XdFFvM244SmFzX1FnRk9GVVFHejllVUJRcWc2YkdjQnJKZE13Nk8yOC1XUWlZMy0waTBtUVJBZDhZM2xHT2pPVlNkelJLUk5WV1NoVnAxNWxmdnFjWTlvZ0lkeWNkODNYMURJcXIwMUhld0k2Qjh6Z1I5a0Qwc2o4aklLNzZvZXhCaEh3WFd0aFh1X19kUU1VWmJmaGt0U0NXbVRKamQ0T3NVbUtLVEpOY1oteVk?oc=5","date":"2025-01-15","type":"pipeline","source":"Investors in Healthcare","summary":"Switzerland: Windward Bio launches with US$200m Series A - Investors in Healthcare","headline":"Switzerland: Windward Bio launches with US$200m Series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE1KVnJEZjcyQ1luU0d2VDNXR2xHRXQzam84dVF5dGh3LTRoaDJLa3hIN2xRYVdCeHVZaldqMTRkYkJNRnhqQVBRMHhFekstSGcwZTRBcHludDBtRXBiTktSM1Q5aXYzbmlaRkZ4c185YURXck0?oc=5","date":"2025-01-13","type":"pipeline","source":"Pharmaceutical Executive","summary":"Novo Holdings Invests in Windward Bio - Pharmaceutical Executive","headline":"Novo Holdings Invests in Windward Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOWk11VHhTMmg2dXR2MGhGWXpIOVM2eDVIalBsTGFRR0lwV0d3SS1jaUQ3azJ6amFyRVZ4enNpLTNYQTZubkNSR3JOdDVxaWh2V3VfUkhhQTVib0l2MDQ1WHBERjk1dHo1TWZSdkV3TEdhSE9wT09sWjlIaUFvVEl5TzIyaEI1amlDNERJZDF2V2NuWXdvZEdISkNtRzhDTHFRWHI1UmNHSk5aTzdsUUloX3hvdEVxNEpJbjZkd1RVSmc2LUhsMmpQQWctUFAzMzhx?oc=5","date":"2025-01-13","type":"pipeline","source":"Yicai Global","summary":"Harbour BioMed, Kelun-Biotech Grant Windward Bio Global Rights to Anti-TSLP Antibody for USD970 Million - Yicai Global","headline":"Harbour BioMed, Kelun-Biotech Grant Windward Bio Global Rights to Anti-TSLP Antibody for USD970 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPdldLbm9SRGxZeTJhTkpLSUtCYnJFYzMxRWNEQS13ZjFuSmJrN29Xa2I5aVRxYmNfRHg4MHJIZ3VCZFdfOGUtcTZ6R1VpSkI2aXo4VUFiMWd1SHI5dDRoWjJtUW1ISmQ1RVRhUlF5eUtNZUFsbjNkaURURFRmelVrSlp3LXA2ZmhkN2dmcDVhX3BxWnhOSUJtLTJ2SDgtcGxMSlB3VDlRUHVUcmJpUDZrV1Zn?oc=5","date":"2025-01-10","type":"deal","source":"Contract Pharma","summary":"Harbour BioMed & Kelun-Biotech License TSLP Antibody to Windward Bio - Contract Pharma","headline":"Harbour BioMed & Kelun-Biotech License TSLP Antibody to Windward Bio","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}